Logo image of RTE.CA

ROUTE 109 RESOURCES INC (RTE.CA) Stock Fundamental Analysis

TSX-V:RTE - TSX Venture Exchange - CA7792911033 - Common Stock - Currency: CAD

0.11  -0.01 (-12%)

Fundamental Rating

1

RTE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of RTE have multiple concerns. RTE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RTE has reported negative net income.
RTE had a negative operating cash flow in the past year.
RTE.CA Yearly Net Income VS EBIT VS OCF VS FCFRTE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -1.8%
ROE -1.85%
ROIC N/A
ROA(3y)-1.82%
ROA(5y)N/A
ROE(3y)-1.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RTE.CA Yearly ROA, ROE, ROICRTE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -1 -2 -3 -4

1.3 Margins

RTE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RTE.CA Yearly Profit, Operating, Gross MarginsRTE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, RTE has more shares outstanding
RTE has a worse debt/assets ratio than last year.
RTE.CA Yearly Shares OutstandingRTE.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
RTE.CA Yearly Total Debt VS Total AssetsRTE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

RTE has an Altman-Z score of 2.66. This is not the best score and indicates that RTE is in the grey zone with still only limited risk for bankruptcy at the moment.
RTE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.66
ROIC/WACCN/A
WACCN/A
RTE.CA Yearly LT Debt VS Equity VS FCFRTE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

RTE has a Current Ratio of 6.22. This indicates that RTE is financially healthy and has no problem in meeting its short term obligations.
RTE has a Quick Ratio of 6.22. This indicates that RTE is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 6.22
Quick Ratio 6.22
RTE.CA Yearly Current Assets VS Current LiabilitesRTE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RTE have decreased strongly by -103.82% in the last year.
EPS 1Y (TTM)-103.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RTE.CA Yearly Revenue VS EstimatesRTE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024
RTE.CA Yearly EPS VS EstimatesRTE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RTE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RTE.CA Price Earnings VS Forward Price EarningsRTE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RTE.CA Per share dataRTE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RTE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROUTE 109 RESOURCES INC

TSX-V:RTE (3/6/2025, 7:00:00 PM)

0.11

-0.01 (-12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.89%
Ins Owner ChangeN/A
Market Cap1.84M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.92
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.8%
ROE -1.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.82%
ROA(5y)N/A
ROE(3y)-1.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 202867%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.22
Quick Ratio 6.22
Altman-Z 2.66
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)213006%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.77%
OCF growth 3YN/A
OCF growth 5YN/A